×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| ISHITA DRUGS & INDUSTRIES LTD. | 41.99 | 2.38 | 41.32 | 0.80 | 23.9 | 27.8 |
| PHAARMASIA LTD. | 49.11 | -6.99 | 47.22 | -1.02 | 22.6 | |
| COLINZ LABORATORIES LTD. | 15.44 | 0.53 | 14.67 | NA | 19.5 | 39.8 |
Ishita Drugs & Industries Ltd., with Security Code 524400, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.8 | 3.2 | 2.6 | 3.0 | 4.3 | 3.2 | 4.4 | 3.0 | 3.2 | 4.1 |
| Expenses | 2.7 | 3.1 | 2.4 | 2.9 | 4.2 | 3.0 | 4.2 | 2.9 | 3.0 | 3.8 |
| Operating Profit | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.3 |
| OPM % | 4.9% | 5% | 9.1% | 5.44% | 4.96% | 7.07% | 6.54% | 5.75% | 7.3% | 7.19% |
| Other Income | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.2 | 0.4 | 0.2 | 0.3 | 0.3 |
| Tax % | 25.5% | 23.3% | 28.7% | 24.7% | 23.6% | 25.6% | 23.8% | 25% | 24.8% | 25.2% |
| Net Profit | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.3 | 0.1 | 0.2 | 0.2 |
| EPS in Rs | 0.39 | 0.39 | 0.6 | 0.46 | 0.7 | 0.4 | 0.94 | 0.49 | 0.65 | 0.8 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | 3% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 16% |
| 3 Years: | -3% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 41% |
| 3 Years: | 26% |
| 1 Year: | 2% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|